Effects of hydralazine on uteroplacental and fetal circulations.
D000818:Animals; D000831:Animals, Newborn; D001158:Arteries / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D005260:Female; D005333:Fetus; D006339:Heart Rate / Q000187:drug effects; D006830:Hydralazine / Q000008:administration & dosage / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011247:Pregnancy; D011651:Pulmonary Artery / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012756:Sheep; D014471:Umbilical Veins / Q000187:drug effects; D014599:Uterus / Q000098:blood supply
D002245:Carbon Dioxide; D006830:Hydralazine; D010100:Oxygen